Recent studies in colorectal cancer have demonstrated that POLE mutations can reshape the mRNA expression landscape, supporting the concept of mini-driver genes that exert subtle yet functionally relevant transcriptional effects across multiple pathways [32]. This evidence concerns the gene POLE and colorectal cancer.